Signal active
Contact Information
Social
Primary Organization
2012
0
0
0
11-50
Clean Energy, Agriculture
Bio
Dr. Opgenorth serves part-time as Vice President of CSU Ventures, and Executive Director for NeoTREX® the enterprise arm of Colorado State University's Cancer Supercluster.
He joined CSU Ventures after retiring in 2007 from Abbott Laboratories, where he was Divisional Vice President of Metabolic Disease Research, Antiviral Research and Target-Lead Discovery Research for Abbott's Global Pharmaceutical Research and Development Division. At Abbott he championed a number of biotechnology collaborations, and led teams that advanced multiple drug candidates into clinical development.
He is also a Volwiler Fellow. Dr. Opgenorth serves as a Director on Boards of Keystone Symposia, KromaTiD, and Cetya, and serves on Scientific Advisory Boards for Keystone Symposia and Euroscreen, SA. Along with being founder and CSO of VetDC, he is acting CEO of Vidasym, Inc., a discovery company developing drugs for treatment of human chronic kidney disease.
He holds a BA in Biology from Calvin College, and MS and PhD degrees in Physiology from University of Illinois-Urbana.
Location
N/A
Jobs history
2
Photonpharma
CEO
2022 - 2023
Photonpharma
Chair of the Board
2022 - Current
Educations
2
Calvin University
Biology
University of Illinois Urbana-Champaign
Physiology
Profile Resume
Terry Opgenorth is the Vice President at CSU Ventures. With a background in Clean Energy, Terry Opgenorth has a rich history of leadership and innovation.Terry Opgenorth studied unknown Biology at Calvin University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Products and Innovations
0
There is no product and inovations for this profile.
Achievements
0
There is no Achievements for this profile.
Publications
0
There is no publication for this profile.
Recent Activity
There is no recent news or activity for this profile.